There were 568 press releases posted in the last 24 hours and 158,788 in the last 365 days.

The Latest Innovations in HPAPI Manufacturing Technologies


A focus on alternative HPAPI manufacturing technologies

LONDON, UNITED KINGDOM, July 9, 2019 / -- SMi’s inaugural Highly Potent Active Pharmaceutical Ingredients USA Conference, will focus on the latest innovative manufacturing technologies with a special spotlight presentation on effective and safe containment solutions for biologics based HPAPIs, along with cleaning and cross contamination requirements.

Keith Jensen, Owner and Consultant at Keith Jensen Consulting, previously at Novartis-MIT Center for Continuous Manufacturing, discusses alternative HPAPI manufacturing technologies to reduce powder exposure and improve safety enabling continuous manufacturing. Other points to be discussed include:

- Alternative drug manufacture through nanocrystal formulations, thin films and hot-melt extrusion/injection molding that reduces HPAPI powder exposure and improve safety
- Step-by-step processes along with the equipment needed to achieve alternative HPAPI manufacturing techniques

Richard Denk, Head of Sales Containment from SKAN focuses on:
- Regulatory requirements for highly potent biologics-based Pharmaceuticals
- Requirements for aseptic manufacturing and Containment
- Cleaning and Cross Contamination Requirements

Also, up for discussion will be emerging bispecific HPAPI therapy, from development to manufacturing and multipurpose facilities, along with what level of super high-level band 5 containment is required.

For those interested, a special discounted rate is available for conference tickets booked before August 30th. Register online at

Sponsored by BSP Pharmaceuticals | LONZA | Minakem | SafeBridge Consultants

Highly Potent Active Pharmaceutical Ingredients USA
Conference: October 21st – 22nd
Workshops: October 23rd
Venue: Sheraton Boston Hotel, USA

For delegate enquiries, please contact Fateja Begum on +44 (0)20 7827 6184 or

For sponsorship, exhibition and branding enquiries, please contact Alia Malick on +44 (0)20 7827 6168 or

For media enquiries contact Neill Howard on Tel: +44 (0)20 7827 6164 or

Neill Howard
SMi Group Ltd
+44 20 7827 6000
email us here

EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.